The Incraft stent graft for the treatment of abdominal aortic aneurysms: an iliac-friendly device with an effective conventional proximal sealing mechanism

ABSTRACT

Introduction

The Incraft aortic stent graft (Cordis, Bridgewater, NJ, USA) is a trimodular endovascular stent graft with a conventional suprarenal active fixation specifically designed to overcome the anatomic limitation of small, stenotic, and tortuous iliac vessels.

Areas covered

The present article provides a complete description of the Incraft stent graft, its clinical performance, its technical characteristics as well as a comparison with other competitive endografts.

Expert opinion

The Incraft stent graft is an EVAR ultra low-profile device initially designed for overcoming the limitation of the hostile iliac anatomy. Recently, the device is being increasingly used in real-world conditions and not only in complex iliac anatomies with good mid-term results. Whether it remains a useful EVAR toolbox or will become a workhorse endograft is yet to be determined.

KEYWORDS:

• Incraft
• EVAR
• abdominal aortic aneurysm
• endograft
• low-profile device

Article Highlights

• The Incraft stent graft has proven its efficacy in EVAR, particularly in patients with stenotic iliac arteries, such as women and people of Asian origin.

• It combines the navigability through hostile iliac anatomy with the adaptability to most neck anatomies using the conventional and well-tested sealing mechanism of the nitinol-based endografts without the need for polymers.

• Its low profile (14 Fr) allows the percutaneous treatment of AAA, which shortens the mean hospital stay of the patients.

• The high rate of stent fractures and the contralateral iliac limb catheterization`s difficulty are issues that need to be improved.

• Whether the Incraft stent graft remains a useful EVAR toolbox or becomes a workhorse endograft is yet to be determined.

Declaration of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This paper was not funded.